MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M.
Right arrow Articles by Jakobs, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M.
Right arrow Articles by Jakobs, K. H.

Vol. 53, Issue 6, 1139-1148, June 1998

Gi- and Protein Kinase C-Mediated Heterologous Potentiation of Phospholipase C Signaling by G Protein-Coupled Receptors

Martina Schmidt, Barbara Lohmann, Kerstin Hammer, Stephan Haupenthal, Matthias Voß, Christoph Nehls, and Karl H. Jakobs

Institut für Pharmakologie, Universitätsklinikum Essen, D-45122 Essen, Germany

We recently reported that activation of the highly efficient phospholipase C (PLC) stimulatory m3 muscarinic acetylcholine receptor (mAChR) can induce a long-lasting Gi-mediated heterologous potentiation of PLC stimulation in human embryonic kidney (HEK) 293 cells, which was accompanied by an increased cellular level of the PLC substrate phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P2]. Here, we examined whether such a potentiated PLC response is also induced by the rather poorly PLC stimulatory m2 mAChR and the endogenously expressed purinergic and lysophosphatidic acid receptors. Pretreatment of m2 mAChR-expressing HEK 293 cells for 2 min with carbachol, followed by agonist washout and measurement of PLC activity >= 40 min later, caused a long-lasting (up to ~90 min) heterologous potentiation of receptor- and G protein-mediated PLC stimulation. A similar heterologous potentiation of receptor-mediated PLC stimulation was induced by short term activation of lysophosphatidic acid and purinergic receptors. Either of the three receptor agonists increased the cellular level of PtdIns(4,5)P2 by ~50%. The mAChR-induced PLC potentiation was fully prevented by either pertussis toxin or the protein kinase C (PKC) inhibitors staurosporine and Gö 6976, which did not affect acute PLC stimulation. On the other hand, the rise in PtdIns(4,5)P2 was prevented only by combined treatment of HEK 293 cells with pertussis toxin and PKC inhibitors. In conclusion, we demonstrated that activation of poorly PLC stimulatory receptors can also induce a long-lasting Gi-mediated heterologous potentiation of PLC signaling in HEK 293 cells and that this novel PLC regulatory process is under the control of PKC.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. I. A. Roach, R. A. Rebres, I. D. C. Fraser, D. L. DeCamp, K.-M. Lin, P. C. Sternweis, M. I. Simon, and W. E. Seaman
Signaling and Cross-talk by C5a and UDP in Macrophages Selectively Use PLC{beta}3 to Regulate Intracellular Free Calcium
J. Biol. Chem., June 20, 2008; 283(25): 17351 - 17361.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. I. Abdullah, P. L. Pedraza, J. C. McGiff, and N. R. Ferreri
CaR activation increases TNF production by mTAL cells via a Gi-dependent mechanism
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F345 - F354.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Cheng, J. A. Grodnitzky, S. Yibchok-anun, J. Ding, and W. H. Hsu
Somatostatin Increases Phospholipase D Activity and Phosphatidylinositol 4,5-bisphosphate Synthesis in Clonal {beta} Cells HIT-T15
Mol. Pharmacol., June 1, 2005; 67(6): 2162 - 2172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Pedrosa, P. Gomes, U. Hopfer, P. A. Jose, and P. Soares-da-Silva
Gi{alpha}3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event
Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1059 - F1066.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Drakulich, A. M. Walls, M. L. Toews, and T. D. Hexum
Neuropeptide Y Receptor-Mediated Sensitization of ATP-Stimulated Inositol Phosphate Formation
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Blaukat, A. Barac, M. J. Cross, S. Offermanns, and I. Dikic
G Protein-Coupled Receptor-Mediated Mitogen-Activated Protein Kinase Activation through Cooperation of Galpha q and Galpha i Signals
Mol. Cell. Biol., September 15, 2000; 20(18): 6837 - 6848.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. S. C. Chan, J. W. M. Lee, M. K. C. Ho, and Y. H. Wong
Preactivation Permits Subsequent Stimulation of Phospholipase C by Gi-Coupled Receptors
Mol. Pharmacol., April 1, 2000; 57(4): 700 - 708.
[Abstract] [Full Text]


Home page
BloodHome page
M. G. Cifone, G. Migliorati, R. Parroni, C. Marchetti, D. Millimaggi, A. Santoni, and C. Riccardi
Dexamethasone-Induced Thymocyte Apoptosis: Apoptotic Signal Involves the Sequential Activation of Phosphoinositide-Specific Phospholipase C, Acidic Sphingomyelinase, and Caspases
Blood, April 1, 1999; 93(7): 2282 - 2296.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Schmidt, M. Frings, M.-L. Mono, Y. Guo, P. A. O. Weernink, S. Evellin, L. Han, and K. H. Jakobs
G Protein-coupled Receptor-induced Sensitization of Phospholipase C Stimulation by Receptor Tyrosine Kinases
J. Biol. Chem., October 13, 2000; 275(42): 32603 - 32610.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics